After bankruptcy filing, Purdue Pharma… not be off hook

The company and members of the Sackler family, which owns it, expressed sympathy but not responsibility.

“Like families across America, we have deep compassion for the victims of the opioid crisis,” family members said in a statement, calling the settlement plan a “historic step towards providing critical resources that address a tragic public health situation.” But the bankruptcy filing, made late Sunday [9/15/2019], may not get either the drugmaker or the Sacklers off the legal hook. But a number of the other states that are holding out have made it clear that they intend to object to the deal in bankruptcy court and seek to continue their lawsuits against members of the Sackler family. In all, the company is facing some 2,600 lawsuits, mostly from local governments. It will be up to federal bankruptcy Judge Robert Drain in White Plains, New York, to decide whether to approve the settlement, and also whether those state lawsuits can continue. A court hearing on the bankruptcy plan is expected Tuesday [9/17/2019]. For Purdue and the Sacklers, the effort revolves around getting more states to agree to the settlement, which could make approval more likely. “At every turn, we will fight their craven strategy to use bankruptcy to shield their wealth & to evade our claims to secure billions of dollars for addiction science & treatment,” Connecticut Attorney General William Tong [said] Monday [9/16/2019].

Original Article (CTVNews):
After bankruptcy filing, Purdue Pharma… not be off hook
Artwork Fair Use: Sigmavarialia